 | Equillium (NASDAQ:EQ) Earns Buy Rating from Analysts at Jonestrading marketbeat.com - March 3 at 7:37 AM |
 | Equillium, Inc. (NASDAQ:EQ) Sees Large Growth in Short Interest americanbankingnews.com - March 6 at 11:00 AM |
 | Equillium (NASDAQ:EQ) Coverage Initiated at Jonestrading americanbankingnews.com - March 3 at 8:28 AM |
 | Equillium to Present at the H.C. Wainwright Global Life Sciences Conference - GlobeNewswire globenewswire.com - March 2 at 9:23 AM |
 | Equillium to Present at the H.C. Wainwright Global Life Sciences Conference finance.yahoo.com - March 2 at 9:23 AM |
 | Equillium (NASDAQ:EQ) Stock Price Up 6% americanbankingnews.com - March 1 at 9:00 PM |
 | Equillium, Inc. (NASDAQ:EQ) Expected to Announce Earnings of -$0.38 Per Share americanbankingnews.com - February 28 at 10:24 AM |
 | Equillium (NASDAQ:EQ) Trading Down 11.3% americanbankingnews.com - February 23 at 8:32 PM |
 | Equillium to Present at the SVB Leerink 10th Annual Global Healthcare Conference - GlobeNewswire globenewswire.com - February 18 at 8:38 AM |
 | Equillium to Present at the SVB Leerink 10th Annual Global Healthcare Conference finance.yahoo.com - February 18 at 8:38 AM |
|
 | Equillium (NASDAQ:EQ) Trading Down 6.5% americanbankingnews.com - February 16 at 10:12 PM |
 | Equillium, Inc. (NASDAQ:EQ) Forecasted to Earn Q4 2020 Earnings of ($0.36) Per Share americanbankingnews.com - February 15 at 1:04 AM |
 | Equillium (EQ) Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease - StreetInsider.com streetinsider.com - February 13 at 12:55 AM |
 | Equillium posts interim data from early-stage - Seeking Alpha seekingalpha.com - February 13 at 12:55 AM |
 | Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience - Yahoo Finance finance.yahoo.com - February 12 at 5:33 PM |
 | Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience finance.yahoo.com - February 12 at 5:33 PM |
 | Equillium, Inc. Expected to Earn FY2020 Earnings of ($1.59) Per Share (NASDAQ:EQ) americanbankingnews.com - February 12 at 7:06 AM |
 | Equillium (EQ) Announces Katherine Xu, Ph.D. to Board - StreetInsider.com streetinsider.com - February 9 at 7:51 PM |
 | Equillium Announces the Appointment of Katherine Xu to the Board of Directors - GlobeNewswire globenewswire.com - February 9 at 8:22 AM |
 | Equillium Announces the Appointment of Katherine Xu to the Board of Directors finance.yahoo.com - February 9 at 8:22 AM |
 | Could The Equillium, Inc. (NASDAQ:EQ) Ownership Structure Tell Us Something Useful? finance.yahoo.com - February 7 at 1:37 PM |
 | Equillium Announces Closing of $30 Million Registered Direct Offering - GlobeNewswire globenewswire.com - February 5 at 8:00 PM |
 | Equillium Announces Closing of $30 Million Registered Direct Offering finance.yahoo.com - February 5 at 8:00 PM |
 | Equillium Announces Pricing of $30 Million Registered Direct Offering - Yahoo Finance finance.yahoo.com - February 4 at 11:33 PM |
 | 60 Stocks Moving In Thursday's Mid-Day Session Benzinga - Benzinga benzinga.com - February 4 at 5:30 PM |
 | Why Is It Moving? Analyzing The Upward Movement in Equillium's Stock Today - Benzinga benzinga.com - February 4 at 5:30 PM |
 | Equillium Raises $30M Via Equity, Shares Rally - Benzinga benzinga.com - February 4 at 5:30 PM |
 | Equillium prices $30M registered direct offering - Seeking Alpha seekingalpha.com - February 4 at 5:30 PM |
|
 | Why Is It Moving? Analyzing The Upward Movement in Equillium's Stock Today msn.com - February 4 at 12:30 PM |
 | Equillium Announces Pricing of $30 Million Registered Direct Offering - GlobeNewswire globenewswire.com - February 4 at 8:31 AM |
 | Equillium Announces Pricing of $30 Million Registered Direct Offering finance.yahoo.com - February 4 at 8:31 AM |
 | Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience - Yahoo Finance finance.yahoo.com - January 22 at 8:59 AM |
 | Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience finance.yahoo.com - January 22 at 8:59 AM |
 | Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference - GlobeNewswire globenewswire.com - January 7 at 9:57 AM |
 | Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference - Yahoo Finance finance.yahoo.com - January 5 at 9:23 AM |
 | Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference finance.yahoo.com - January 5 at 8:47 AM |
 | Mid-Morning Market Update: Markets Open Higher; UK Approves AstraZeneca's Coronavirus Vaccine For Emergency Use - Benzinga benzinga.com - December 30 at 10:37 PM |
 | Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer - GlobeNewswire globenewswire.com - December 21 at 5:25 PM |
 | Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical bloomberg.com - December 21 at 1:29 PM |
 | Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer - Yahoo Finance finance.yahoo.com - December 21 at 12:25 PM |
 | Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer finance.yahoo.com - December 21 at 8:28 AM |
 | Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition - GlobeNewswire globenewswire.com - December 7 at 4:09 PM |
 | Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition - Yahoo Finance finance.yahoo.com - December 7 at 9:10 AM |
 | Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition finance.yahoo.com - December 7 at 9:09 AM |
 | Form 8-K Equillium, Inc. For: Dec 04 - StreetInsider.com streetinsider.com - December 4 at 5:45 PM |
 | Biocon's partner to not initiate Itolizumab Ph 3 trials, co seeks to modify Ph 4 trials in India msn.com - December 3 at 8:57 AM |
 | BUZZ-U.S. STOCKS ON THE MOVE-Sundial Growers, Nutrien, Equillium, Oil stocks - Nasdaq nasdaq.com - November 30 at 5:15 PM |
 | Equillium to Host Virtual Investor and Analyst Day on December 4, 2020 - GlobeNewswire globenewswire.com - November 30 at 5:15 PM |
 | Equillium to Host Virtual Investor and Analyst Day on December 4, 2020 - Yahoo Finance finance.yahoo.com - November 30 at 8:25 AM |
 | Equillium to Host Virtual Investor and Analyst Day on December 4, 2020 finance.yahoo.com - November 30 at 8:25 AM |
 | Equillium (EQ) Stalls Initiation of Phase III Study on COVID-19 - Yahoo Finance finance.yahoo.com - November 27 at 12:35 AM |